Everything below concerns Preclinical research. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-05-15. Numbers and descriptions here follow the published literature rather than marketing material.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
=== Development === On July 23, 2020, the series was renewed for a third season at the aftershow hosted by Aisha Tyler for the 2020 San Diego Comic-Con@Home, less than two months before the second-season premiere. Showrunner Eric Kripke revealed that he was already working with the scripts for the season in October, hoping to have them finished and start production in early 2021 as long as the condition of the COVID-19 pandemic improved. Due to the restrictions of live-action productions during the pandemic, Kripke and the producers have the idea of keeping the fans of the series engaged while they waited for the release of the third season, leading to the anthology animated spin-off miniseries The Boys Presents: Diabolical. In January 2022, it was confirmed that the season would be getting eight episodes and that would be also following the same weekly release similarly to the previous season, with three episodes released on the premiere date and the rest being released on a weekly basis.
=== Types of toxicity === Acute toxicity occurs over hours or a few days. Chronic toxicity results from adult daily intakes greater than 25,000 IU for 6 years or longer and more than 100,000 IU for 6 months or longer.
== Products == There are thought to be a number of useful products that can potentially be manufactured in space and result in an economic benefit. Research and development is required to determine the best commodities to be produced, and to find efficient production methods. The following products are considered prospective early candidates:
=== Second week (28 February – 6 March) === On 28 February, clashes between Pakistan border guards and Afghan Taliban were reported along the border areas of Torkham. Later on, an airstrike was carried out by the PAF on Jalalabad Airport, the capital of Nangarhar province. An AFP journalist reported hearing sounds of two loud explosions from the direction of Jalalabad airport. Pakistan's media outlet also reported an airstrike in Nangarhar province targeting several Taliban headquarters. On the same day, Afghan forces claimed a Pakistani fighter was shot down over Jalalabad using anti-aircraft guns, with the pilot captured alive. Pakistan rejected the Afghan Taliban's claim, labeling it as wartime propaganda. Afterwards, the detained individual was severely beaten by the Afghan Taliban and locals, while being paraded through the market area in Jalalabad, with Taliban officials terming the event as an important war operation. However, later on, it was revealed that the pilot that Afghan forces captured was an ordinary Afghan national who was a parachutist and had no connection to the Pakistani army. Further investigation also revealed that news of downing a fighter jet was false, and the detained individual was later released.
== Further reading == Ahnström, M. L.; Seyfert, M.; Hunt, M. C.; Johnson, D. E. (2006). "Dry aging of beef in a bag highly permeable to water vapor". Meat Science. 73 (4): 674–679. doi:10.1016/j.meatsci.2006.03.006. PMID 22062568. DeGeer, S. L.; Hunt, M. C.; Bratcher, C. L.; Crozier-Dodson, B. A.; Johnson, D. E.; Stika, J. F. (2009). "Effects of dry aging of bone-in and boneless strip loins using two aging processes for two aging times". Meat Science. 83 (4): 768–774. doi:10.1016/j.meatsci.2009.08.017. PMID 20416624.
Sources: en.wikipedia.org
== Biological activity == Concanavalin A interacts with diverse receptors containing mannose carbohydrates, notably rhodopsin, blood group markers, insulin receptors, the immunoglobulins and the carcino-embryonary antigen (CEA). It also interacts with lipoproteins. ConA strongly agglutinates erythrocytes irrespective of blood-group, and various cancerous cells. It was demonstrated that transformed cells and trypsin-treated normal cells do not agglutinate at 4 °C, thereby suggesting that there is a temperature-sensitive step involved in ConA-mediated agglutination. ConA-mediated agglutination of other cell types has been reported, including muscle cells, B-lymphocytes (through surface immunoglobulins), fibroblasts, rat thymocytes, human fetal (but not adult) intestinal epithelial cells, and adipocytes. ConA is a lymphocyte mitogen. Similar to phytohemagglutinin (PHA), it is a selective T cell mitogen relative to its effects on B cells. PHA and ConA bind and cross-link components of the T cell receptor, and their ability to activate T cells is dependent on expression of the T cell receptor. ConA interacts with the surface mannose residues of many microbes, including the bacteria E. coli, and Bacillus subtilis and the protist Dictyostelium discoideum. It has also been shown as a stimulator of several matrix metalloproteinases (MMPs). ConA has proven useful in applications requiring solid-phase immobilization of glycoenzymes, especially those that have proved difficult to immobilize by traditional covalent coupling.
Explaining the Iranian decision, an Iranian national security spokesperson, Ebrahim Rezaei, said "Pakistan is a good friend and neighbor of ours, but it is not a suitable intermediary for negotiations and lacks the necessary credibility for mediation." He claimed that Pakistan would always take Trump's interests into account and often overlook his violation of agreements. "A mediator must be impartial, not always leaning to one side," Rezaei stated. On 21 April, German foreign minister Johann Wadephul said that Iran should engage in talks with the US "for the people's sake". Vahid Ahmadi, a member of the Iranian parliament's national security commission, said that if the US did not accept Iran's demands, they would continue the war. A senior Iranian source said that Iran was not open to discussing its missile program. Chancellor of Germany Friedrich Merz stated that Iranian leaders have "humiliated" US leaders by making them travel to Islamabad and returning back with no result. US senator Lindsey Graham stated that he didn't trust Pakistan with the negotiations due to reports that an Iranian military aircraft was sheltered during the talks. He remarked, "No wonder this damn thing is going nowhere." He later also remarked that Pakistan's role as a mediator was "problematic" while citing the country's anti Israel stance and its position on Abraham Accords.
Prior to this, babies born in different states had received different levels of screening. On April 24, 2008, President George W. Bush signed into law the Newborn Screening Saves Lives Act of 2007. This act was enacted to increase awareness among parents, health professionals, and the public on testing newborns to identify certain disorders. It also sought to improve, expand, and enhance current newborn screening programs at the state level.
== As a pollutant == Although many militaries are replacing traditional 2,4,6-trinitrotoluene (TNT)-based explosives for insensitive munitions, DNP is a degradation byproduct of the IMX-101 insensitive munition used by the United States Army. While the Meisenheimer charge transfer reaction is effective at detecting TNT, it is not effective at detecting many other explosives including DNP. Researchers are studying colorimetric detection and other methods for DNP to find if water or solids such as soils are contaminated with DNP. UiO-66-NH2 can be used to bind to and remove DNP from solution.
Sources: en.wikipedia.org
Failed coup No regime change, as when a leader is illegally shuffled out of power without changing the ruling group or the type of government Replacement of incumbent with another dictatorship Ousting of the dictatorship followed by democratization (also called "democratic coups") The study found that about half of all coups in dictatorships—both during and after the Cold War—install new autocratic regimes. New dictatorships launched by coups engage in higher levels of repression in the year after the coup than existed in the year before the coup. One-third of coups in dictatorships during the Cold War and 10% of later ones reshuffled the regime leadership. Democracies were installed in the wake of 12% of Cold War coups in dictatorships and 40% of post-Cold War ones. Coups occurring in the post-Cold War period have been more likely to result in democratic systems than Cold War coups, though coups still mostly perpetuate authoritarianism. Coups that occur during civil wars shorten the war's duration.
==== Dopamine receptor agonists ==== Apomorphine (Apofin; CHF-1526) – non-selective dopamine receptor agonist and other actions [330] Apomorphine subcutaneous (APO-go; Apokinon; Apokyn; Apomine; Britaject; KW-6500; Li Ke Ji; Movapo; Onapgotm; SPN-830) – non-selective dopamine receptor agonist and other actions [331] Bromocriptine (Parlodel) – dopamine D2-like receptor agonist and other actions Cabergoline (Dostinex) – dopamine D2-like receptor agonist and other actions Dihydroergocryptine (DHEC; Almirid; Cripar) – dopamine D2-like receptor agonist and other actions Lisuride (Dopergin) – dopamine D2-like receptor agonist and other actions Pergolide (Permax) – dopamine D2-like receptor agonist and other actions Piribedil (Trivastal, Pronoran) – dopamine D2-like receptor agonist and other actions Pramipexole (BI-Sifrol; Daquiran; Mirapex; Mirapexin; Pexola; Sifrol; SND-919; SND-919Y) – dopamine D2, D3, and D4 receptor agonist [332] Ropinirole (Adartrel; Repreve; Requip) – dopamine D2, D3, and D4 receptor agonist [333] Ropinirole (Requip CR; Requip LP; Requip XL; Requip XR; SKF-101468A) – dopamine D2, D3, and D4 receptor agonist [334] Ropinirole transdermal (Haruropi Tape; HP-3000) – non-selective dopamine receptor agonist and other actions [335] Rotigotine transdermal (Leganto; N-0437; N-0923; Neupro; Neupro Patch; Nubrenza; SPM-962) – non-selective dopamine receptor agonist and other actions [336] Talipexole (BHT-920; Domin) – dopamine D2 receptor agonist and α2-adrenergic receptor agonist [337]
2 CH3CH=CH2 + 3 O2 + 2 NH3 → 2 N≡CCH=CH2 + 6 H2O In the production of acrylonitrile, a side product is acetonitrile. On an industrial scale, several derivatives of benzonitrile, phthalonitrile, as well as Isobutyronitrile are prepared by ammoxidation. The process is catalysed by metal oxides and is assumed to proceed via the imine. Ammoxidation is a heterogeneously catalyzed gas-phase reaction in which aliphatic or methyl-substituted aromatic compounds react with oxygen (air) and ammonia to form nitriles, with water as a by-product. Reaction temperatures exceed 300 °C, and oxides of vanadium, chromium, or molybdenum serve as catalysts. Acrylonitrile, an important precursor for polymer production (see Use section), is primarily manufactured by ammoxidation of propene. The principal industrial route to hydrogen cyanide is the Andrussov process, i.e., ammoxidation of methane over a platinum catalyst. However, a significant proportion of global hydrogen cyanide production arises as a by-product of acrylonitrile manufacture.
Afghanistan makes up almost two thirds of the land under illicit opium poppy cultivation in the world. The opiate trade originating in Afghanistan fuels the corruption throughout the country by funding the Taliban and their activities. This has been confirmed through drug seizures made by the CMF, who have concluded that the drugs originated from areas in Afghanistan controlled by the Taliban, by using a combination of the drug stamps found on the bags of heroin, and the isotope testing of the poppy gum. The UNODC estimated that in 2009 alone, the Taliban received 140-170 million USD from the opiate trade. This has also had social implications for the population, with an estimated 2 - 2.5 million people using drugs in Afghanistan alone.
==== Horticulture ==== Some horticulturists and users of hydroponics advocate the use of weak hydrogen peroxide solution in watering solutions. Its spontaneous decomposition releases oxygen that enhances a plant's root development and helps to treat root rot (cellular root death due to lack of oxygen) and a variety of other pests. For general watering concentrations, around 0.1% is in use. This can be increased up to one percent for antifungal actions. Tests show that plant foliage can safely tolerate concentrations up to 3%.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
Dihexa is a synthetic peptide-like compound studied in preclinical research. It is often described as an angiotensin IV analog, but it is not an approved medicine. Public information comes mainly from laboratory work and commercial listings.